Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 1—January 2024
Dispatch

Tuberculosis Diagnostic Delays and Treatment Outcomes among Patients with COVID-19, California, USA, 2020

Emily Han1, Scott A. Nabity1Comments to Author , Shom Dasgupta-Tsinikas, Ramon E. Guevara, Marisa Moore, Ankita Kadakia, Hannah Henry, Martin Cilnis, Sonal Buhain, Amit Chitnis, Melony Chakrabarty, Ann Ky, Quy Nguyen, Julie Low, Seema Jain, Julie Higashi, Pennan M. Barry, and Jennifer Flood
Author affiliations: California Department of Public Health, Richmond, California, USA (E. Han, S.A. Nabity, H. Henry, M. Cilnis, S. Jain, P.M. Barry, J. Flood); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S.A. Nabity, M. Moore); Los Angeles County Department of Public Health, Los Angeles, California, USA (S. Dasgupta-Tsinikas, R.E. Guevara, J. Higashi); San Diego County Health and Human Services Agency, San Diego, California, USA (M. Moore, A. Kadakia); Alameda County Public Health Department, San Leandro, California, USA (S. Buhain, A. Chitnis); Sacramento County Health Services, Sacramento, California, USA (M. Chakrabarty); Santa Clara County Public Health Department, San Jose, California, USA (A. Ky); Orange County Health Care Agency, Santa Ana, California, USA (Q. Nguyen, J. Low)

Main Article

Table 2

Hospitalizations for 51 persons who might have experience TB diagnostic delay in a study of TB diagnostic delays and treatment outcomes among patients with COVID-19, California, USA, 2020*

Disease-associated hospitalization† No. admissions Median duration, d (IQR) Range, d Cumulative hospital days ICU and intubation In-hospital death‡
Total 73 12.0 (7.0‒21.0) 1‒139 1,324 14 6
TB only 35 (47.9) 13.0 (8.0‒21.0) 1‒74 634 5 (14.3) 0 (0.0)
TB and COVID-19§ 23 (31.5) 10.0 (5.0‒20.0) 1‒139 392 5 (21.7) 4 (17.4)
COVID-19 only 15 (20.5) 12.0 (6.0‒26.0) 3‒68 298 4 (26.7) 2 (13.3)

*TB–COVID-19 co-infected patients had TB and COVID-19 diagnoses within 120 d of each other, whereby >1 of the diseases was diagnosed in 2020. Included California jurisdictions were Alameda, Los Angeles, Orange, Sacramento, San Diego, and Santa Clara Counties. Values are no. (%) except where indicated. ICU, intensive care unit; TB, tuberculosis. †Based on the timing of hospitalization and diagnosis for each disease. Distinct TB-associated and COVID-19–associated hospitalizations must have occurred >14 d apart. Persons who were hospitalized at any point had an average 1.3 hospitalizations each. ‡Patients who died in hospital had admission durations of 10‒57 d. §Concurrent TB and COVID-19 were addressed in same hospital stay.

Main Article

1These first authors contributed equally to this article.

Page created: November 13, 2023
Page updated: December 20, 2023
Page reviewed: December 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external